EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is a specialized biopharmaceutical company dedicated to developing therapies with groundbreaking potential. The company has strong market positions in neurology, endocrinology, and reproductive health. EMD Serono has an enduring commitment to solve the unsolvable, with state-of-the-art science dedicated to developing new therapies in our core focus areas of neurology, oncology, immuno-oncology, and immunology. The company’s US footprint continues to grow, with approximately 1,000 employees around the country and fully integrated commercial, clinical, and research operations in the company’s home state of Massachusetts.
